Detalhe da pesquisa
1.
Antitumor activity of lurbinectedin (PM01183) and doxorubicin in relapsed small-cell lung cancer: results from a phase I study.
Ann Oncol
; 28(10): 2559-2566, 2017 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28961837
2.
MET phosphorylation predicts poor outcome in small cell lung carcinoma and its inhibition blocks HGF-induced effects in MET mutant cell lines.
Br J Cancer
; 105(6): 814-23, 2011 Sep 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-21847116